Yuan P. Xiong
1200 Cailun Road
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Radiation-resilient monolithic wide-bandgap perovskite/p-type heterojunction silicon tandem solar cells for space photovoltaics.
Journal: Science advances
Published: July 29, 2026
Marine-Derived Bromotyrosine Alkaloids as Potent hCYP1B1 Inhibitors to Overcome Paclitaxel Resistance.
Journal: Journal of medicinal chemistry
Published: January 30, 2026
Characteristics and etiological profile of bilateral adrenal nodules: A Post-hoc analysis.
Journal: Endocrine
Published: October 27, 2025
From degradation to conservation: Tracking mangrove dynamic changes of Hainan Island in China.
Journal: Journal of environmental management
Published: July 14, 2025
An optimized CYP3A4-activatable fluorogenic sensor for in situ functional imaging and multi-dimensional inhibitor assessment.
Journal: Chemical science
Published: March 06, 2025
Pexophagy Triggered by Enterovirus 71 Modulates the Production of Pro-Inflammatory Cytokines Through Cholesterol Accumulation in Lysosomes.
Journal: Journal of medical virology
Published: February 15, 2025
The serious loss of mangrove forest over the largest delta of Africa, Niger Delta: causes and reasons.
Journal: Marine environmental research
Published: December 07, 2024
Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: March 01, 2024
Discovery of 4'-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation.
Journal: European journal of medicinal chemistry
Published: April 12, 2023
Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors.
Journal: Chemico-biological interactions
Published: February 14, 2023
CYP1A inhibitors: Recent progress, current challenges, and future perspectives.
Journal: Medicinal research reviews
Published: December 09, 2022
Serum soluble E-cadherin is a new potential marker for assessing the severity of gout.
Journal: Clinical and experimental rheumatology
Published: April 28, 2022
Last Updated: 09/26/2026